26.08.2016 • NewsDede WillamsRecipharmmanufacturer

Recipharm Lifts Italian Lyophilization Capacity

Sweden-based drug developer and toll manufacturer Recipharm is investing €3.7 million in expanding its lyophilization capacity at Masate, Italy, near Milan. The company said the expansion, which is in response to growing customer demand, forms part of its strategy to become a leading lyophilization provider and at the same time complements its €32 million investment in a capacity increase at Wasserburg, Germany.

Recipharm’s Masate, facility specializes in aseptic manufacturing and filling of parenteral and offers lyophilization capabilities in both vials and ampoules. Part of the expansion will be the introduction of a new lyophilizer for vials, increasing output capability by about 20%.

The new lyophilization machinery will allow the toll manufacturer to support more drug developers with their stability challenges and help meet growing demand for lyophilization services from both small and large drugmakers, particularly in Europe, China and Japan, general manager Giorgio Bruno said.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.